纵横研报
Ticker Detail

600993.SHG

¥24.38+1.33% 马应龙 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Mayinglong Pharmaceutical Group Co Ltd
医疗健康 · 专科与仿制药

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

MARKET 市值 10.02B CNY PE 17.0x Fwd 23.4x 52W ¥21.22 – ¥30.18 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 4.5% ROE 13.5% 营业利润率 24.2% 净利润率 15.1%
ANALYST 股息率 2.94%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制